Delivery Order SPE2DB22D1106-SPE2DB24FEXP5

Award Date 6/18/24
Potential Completion Date 6/20/24
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,960,849 units of the pharmaceutical product Nitrofurantoin Mono-MCR 100 MG. The $1,531.01 firm-fixed-price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, and does not have a set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the federal...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense, to the Amerisourcebergen Drug Corp's Corporate Office Division. The $1,003.54 firm-fixed-price delivery order is for the provision of Nitrofurantoin Mono-MCR 100 mg medication, a common antibiotic drug. The award is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as the primary vehicle for...
This federal contract award, valued at $32,537.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of Nitrofurantoin 25 mg/5 ml suspension, a pharmaceutical product, with a performance period ending on March 26, 2024. The contract is a firm fixed price delivery order, with no set-aside designation....
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency, to Amerisourcebergen Drug Corp, a large pharmaceutical distributor. The $1,153.56 firm-fixed-price delivery order is for the supply of Nitrofurantoin, a prescription medication, with a performance period through August 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,981.85 with a firm fixed price and an ultimate completion date of January 21, 2025. The contract is for the supply of NITROFURANTOIN MONO-MCR 100 MG 100S, a pharmaceutical product. This award is not designated as a set-aside contract. In addition to this specific Delivery Order,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Nitrofurantoin 25 mg/5 ml Suspension, a pharmaceutical product, with a ceiling value of $18,234.82. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Nitrofurantoin 25 mg/5 ml suspension. The $6,848.83 firm-fixed-price contract has a period of performance through May 4, 2022. The contract was awarded on May 3, 2022 and was not set aside for any specific business type. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,946.65 firm-fixed-price contract is for the delivery of 240 ml bottles of the antibiotic drug Nitrofurantoin 25 mg/5 ml suspension. The contract has an ultimate completion date of December 31, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $1,224.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4566340880 - NITROFURANTOIN 25 MG/5 ML SUSP 230ML, with an ultimate completion date of November 6, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 1,000 units of Nitrofurantoin Mono-MCR 100 mg, a prescription medication. The contract has a Firm Fixed Price of $5,065.31 and a completion date of June 4, 2025. AmerisourceBergen Drug Corp is the prime contractor and there is no set-aside designation, indicating open competition. This Delivery Order is issued under a...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FEXP5
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $2,697.66 firm-fixed-price delivery order is for the supply of 4,564,937,473 units of the drug Nitrofurantoin Mono-MCR 100 mg, with a completion date of June 20, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also has a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award was not set aside for any specific business designation.

Generated 9/17/24, 10:11 AM